Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 8,310 shares at $115.09 ($954K) on 2018-06-18, disclosed to the SEC on 2018-06-19.
Open-market sale of $954k ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.90 | 1,268 | $144K | 15.1% |
| 2 | $113.90 | 1,268 | $144K | 15.1% |
| 3 | $115.09 | 2,229 | $257K | 26.9% |
| 4 | $115.09 | 2,229 | $257K | 26.9% |
| 5 | $115.89 | 658 | $76K | 8.0% |
| 6 | $115.89 | 658 |
| $76K |
| 8.0% |
| Total | $114.85 avg | 8,310 | $954K | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |